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Abstract: Non-communicable diseases (NCDs) are currently the leading cause of 
death worldwide. In this paper, we examine the channels through which economic 
growth affects NCDs’ epidemiology. Following a production function approach, we 
develop a basic technique to break up the impact of economic growth on NCDs into 
three fundamental components: (1) a resource effect; (2) a behaviour effect; and (3) 
a knowledge effect. We demonstrate that each of these effects can be measured as 
the product of two elasticities, the output and income elasticity of the three leading 
factors influencing the frequency of NCDs in any population: health care, health-
related behaviours and lifestyle, and medical knowledge.
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1. Introduction
Chronic non-communicable diseases (NCDs)—once considered “diseases of affluence” that affect 
elderly and wealthy people in developed regions—are currently the leading cause of death and dis-
ability worldwide (World Health Organisation [WHO], 2014). The global epidemic of NCDs is widely 
acknowledged as a major threat, not only to human health, but also to health systems and eco-
nomic growth (Bloom et al., 2011).
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There is a complex relationship between economic growth and NCDs. Strengthening the growth 
process does not automatically decrease the burden of NCDs. Sustained economic growth, however, 
tends to create the necessary conditions to tackle NCDs and therefore to improve human health 
(Weil, 2012). Basically, along with education, health is a crucial dimension of human capital, and 
human capital plays a key role in fostering economic growth. In turn, economic growth allows a 
society to decrease both the incidence and the mortality of NCDs by allocating more and better 
resources to health education, health care and medical research (Bloom & Canning, 2000).
Both directions of this interdependent relationship are at the heart of our understanding of the 
economic and social determinants of health (Canning, Bloom, Jaminson, & Ruger, 2012). The emerg-
ing challenge of NCDs has stimulated comprehensive research about the economic burden of these 
pathologies at both the micro- and the macroeconomic level (Engelgau, Rosenhouse, El-Saharty, & 
Mahal, 2011; Suhrcke, Nugent, Stuckler, & Rocco, 2006). In this paper, we reverse this perspective by 
examining the impact of economic growth on NCDs’ epidemiology. Our focus on NCDs is motivated 
by the fact that today “The world has reached a decisive point in the history of NCDs and has an 
unprecedented opportunity to alter its course … The world now has a truly global agenda for preven-
tion and control of NCDs, with shared responsibilities for all countries based on concrete targets” 
(Chan, 2014, p. VII).
In economics, it is usual to model the population health outcome as a function of the causes of 
health using a production function (Grossman, 1972). Following this standard approach, we aim to 
develop a basic technique to break up the impact of economic growth on NCDs into three fundamen-
tal components: (1) a “resource effect”; (2) a “behaviour effect”; and (3) a “knowledge effect”. Within 
this simple framework, each of these effects is the product of two elasticities: the output and income 
elasticity of the three leading factors influencing the frequency of NCDs in any population, namely 
health care, health-related behaviours and lifestyle, and medical knowledge.
The remainder of the paper is structured as follows. In Section 2, we briefly review the concept of 
the health production function. In Sections 3 and 4, we discuss the major effects of economic growth 
on the arguments of the health production function. In Section 5, we attempt to decompose and 
measure the channels through which the growth process affects the mortality rate due to NCDs. 
Finally, Section 6 concludes the paper with an elementary numerical example for explanatory pur-
poses and some comments about the strengths and limitations of the proposed approach.
2. The production of health
From an economic standpoint, health can be regarded as a durable good: an output that people are 
able to produce by combining a set of appropriate medical and non-medical inputs for a given state 
of medical knowledge. A “production function for health” relates the various inputs to the output 
and describes the society’s available health technology (Folland, Goodman, & Stano, 2013).
Within this framework, let us denote by H the age-standardized mortality rate caused by the leading 
NCDs (cancers, diabetes, respiratory and cardiovascular diseases, etc.). Surely, H is influenced by sev-
eral different and interrelated factors. For any given state of medical knowledge (M), however, a health 
production function for H has to be based on at least two fundamental health inputs: health care (HC) 
and people’s health-related behaviours, habits and living conditions (HB) (Sloan & Hsieh, 2012).
For our purposes, it is convenient to express the relationship between these health inputs and the 
population health outcome mathematically, as follows:
 
where HC is a measure of the amount of resources that the society devotes to health care to tackle 
NCDs (i.e. the real per capita expenditure on health care for NCDs), while HB is a measure of the aver-
age population’s exposure to environmental and lifestyle risk factors for NCDs (i.e. an index that 
(1)
H = f (HC
-
,HB
+
,M
-
)
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summarizes all modifiable behaviours and conditions associated with NCDs, taking a value between 
0 and 1—that is, a “perfectly healthy” and a “perfectly unhealthy” situation, respectively). Finally, M 
is a measure of the existing medical knowledge available to prevent and cure NCDs (i.e. the current 
stock of ideas and practices in this field of medical science).
This basic production function simply states that, given M, each society can improve the popula-
tion’s health status either by changing the resource allocation or by affecting people’s lifestyle and 
living environment. In particular, the negative sign below HC and the positive sign below HB in 
Equation 1 reflect the fact that, ceteris paribus—that is, given the genetic characteristics of the 
population under study and holding constant all other cultural, economic and social factors that 
influence health—more resources and fewer exposures (i.e. better health-related behaviours, habits 
and living conditions) exert positive effects on health and thereby lower the age-standardized mor-
tality rate due to NCDs.
Finally, medical knowledge changes in response to breakthroughs in science and technology. A 
flow of new ideas increases the stock of existing knowledge. According to Equation 1, as medical 
science progresses, ceteris paribus, more health can be produced for any given levels of HC and HB, 
again leading to a decrease in H (this is why a negative sign also appears under M in the production 
function).1
3. The health production function during economic growth
In the short run (say, from year to year), the arguments of the health production function are likely 
to be nearly constant or to undergo only minor changes. On the other hand, in the long run (say, 
from decade to decade), economic growth tends to produce deep transformations in both health 
inputs and medical knowledge. More particularly, at a macroeconomic level, changes in HC, HB and 
M are primarily due to structural changes resulting from the interaction of factors operating on the 
demand and the supply side of the economy, respectively (López-Casasnovas, Rivera, & Currais, 
2005).
On the demand side, the individual and collective preferences about health status and the satis-
faction of health needs are not constant during growth. As the real per capita income increases, 
people modify both their consumption patterns and their approval of the public health policies. As a 
result, the population’s demand for health care and health programmes changes, in both quantita-
tive and qualitative terms, and so does the population’s demand for health-related goods (i.e. each 
commodity or service that yields utility, but also affects—positively or negatively—health condi-
tions: food, tobacco and alcohol, environmental quality, etc.) (McQueen, 2013).
On the supply side, the technology available to produce health generally reflects the society’s level 
of economic development. Although income per capita is not the only or best measure of genuine 
economic progress, superior medical techniques, especially better pharmacological and surgical 
treatments, and new tools for early diagnosis and screening usually accompany economic growth in 
a “virtuous cycle” in which growth promotes M and in turn M reinforces the growth process through 
its effects on H (Sachs, 2001; WHO, 2014). An unequal income distribution can have adverse effects 
on people’s access to better health care (Biggs, King, Basu, & Stuckler, 2010; Ecob & Smith, 1999). 
However, in a growing economy, medical improvements tend—in the very long run—to become 
available to larger proportions of the population (either directly by the market mechanism or indi-
rectly through public provision), enhancing the health-related quality of life (Cutler, Deaton, & Lleras-
Muney, 2006; Deaton, 2008; Pritchett & Summers, 1996).
The demand-side structural changes affect preferences and thus they influence primary HC and 
HB, while those relative to the supply side involve technology and thus they influence M foremost. A 
useful way to capture these complex impacts of economic growth on health inputs and medical 
knowledge is to make explicit the dependence of HC, HB and M on income per capita, by using three 
Engel-type2 (Chai & Moneta, 2010) basic functions, as follows:
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in which Y denotes the average real income per person (i.e. the gross domestic product (GDP) per 
capita in constant prices). Equations 2 and 4 describe the positive relationships between growth and 
health expenditure and between growth and medical technology, respectively. They simply state 
that as the real average GDP increases, more resources per capita are spent on health care to pre-
vent and cure NCDs and medical knowledge about NCDs progresses. Conversely, the alternative 
positive and negative signs under Y in Equation 3 express a theoretically ambiguous relation 
between economic growth and the average population’s exposure to environmental and lifestyle 
risk factors for NCDs. We discuss some features of Equation 3 in the following section.
4. Health-related behaviours during economic growth
The leading NCDs have two basic characteristics in common: a complex aetiology and multiple risk 
factors. In the literature, the interaction between the inborn genetic characteristics of individuals 
and numerous external agents—tobacco use, alcohol abuse, an unhealthy diet, a lack of physical 
activity, air pollution, chronic infection and so forth—is well documented (Bonita, Beaglehole, & 
Kjellström, 2006).
A specific feature of these external agents is that they are avoidable or at least modifiable. The 
exposure to NCDs’ external agents therefore changes when people modify their lifestyle and living 
environment, either directly by individual choices (such as variations in tobacco consumption and 
eating patterns) or indirectly through collective choices (such as improvements in environmental 
quality and workplace conditions) (Yach, Mensah, Hawkes, Epping-Jordan, & Steyn, 2012).
From the consumption perspective, goods and services are indeed categorized according to a hier-
archical structure, determined by several biological, cultural and social factors (Argyrous, 2002; 
Pasinetti, 1981). Thus, as income increases, the tendency is not to expand the demand of each good 
and service proportionally. Rather, there are further income threshold levels at which tastes and pref-
erences switch and people start following new consumption patterns (Chai & Moneta, 2013). These 
structural changes affect the exposure to external agents, either in a positive or in a negative direc-
tion, that is, towards a more or less risky situation (thus shifting HB closer to 1 or 0, respectively).
For instance, in its initial stages, the growth process may tend to push populations towards 
unhealthy lifestyles, characterized by an increasing prevalence of smoking, excessive alcohol intake 
and quantitatively/qualitatively incorrect nutrition (such as the routine consumption of animal fat, pro-
tein and calorie-dense foods) (Popkin, 2006). In these circumstances, economic growth is also driven 
by industrialization processes—usually based upon highly polluting production methods—which typi-
cally take place in unsafe and harmful working environments. In its later stages, however, economic 
growth tends to strengthen the population’s concerns about the health consequences of private and 
public choices. As incomes rise, health becomes more and more important in people’s hierarchy of 
needs and wants. The market demand for health-related goods and services (and the political demand 
for better living and working conditions) may thereby evolve in the direction of healthier individual and 
collective lifestyles (Jemal, Center, De Santis, & Ward, 2010; Setterfield, 2002).
5. Economic growth and NCDs: An elasticity approach
The income elasticity of a population’s health conditions (EH,Y) is commonly used to summarize and 
measure the impacts of economic growth on people’s health (Bishai & O’Neil, 2012). Specifically, 
EH,Y is the percentage change in a certain measure of health status—here, the age-adjusted 
(2)
HC = HC(Y
+
)
(3)HB = HB(Y
+∕ -
)
(4)M = M(Y
+
)
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mortality rate due to NCDs—in response to a given percentage change in real income per capita. 
That is, (ΔH/H)/(ΔY/Y) or more usefully:
 
where the coefficient EH,Y is therefore a pure number that describes how much the health status 
responds to a change in income.
Starting from Equation 5, the concept of the health production function can be developed into a 
basic framework to investigate the channels through which economic growth affects NCDs. 
Specifically, by replacing all the arguments of Equation 1 with their expressions from Equations 2, 3 
and 4 gives:
where H is a function of one variable (i.e. it is a function of three functions, all of which have the same 
argument: the real GDP per capita). Thus, by applying the chain rule to Equation 6, we obtain:
 
Thereby, given that EH,Y is the product of dH/dY times the income–health ratio Y/H, we can write 
Equation 5 as follows:
 
or, equivalently, by expanding this equation for Y/H, EH,Y becomes:
 
Finally, for our purposes, the income–health ratio can be more usefully written with one of the three 
following identities:
 
so that replacing Y/H in the first, second and third addends of Equation 9, with its corresponding 
expression taken from Equation 10, gives:
 
where EH,Y is still the sum of three addends, as in Equation 7, but each of these addends is now the 
product of two elasticity coefficients: namely an output elasticity and an income elasticity (the mul-
tiplicand and multiplier of each term of the right-hand side of Equation 11, respectively).
Equation 11 has a simple interpretation. Specifically:
•  the first term is the elasticity of the population’s health status with respect to health care (EH,HC) 
times the income elasticity of HC (EHC,Y). The product of these coefficients (EH,HC × EHC,Y) captures 
the “resource effect” of economic growth on people’s health;
(5)EH,Y =
dH
dY
×
Y
H
(6)H = f [HC(Y),HB(Y),M(Y)]
(7)
dH
dY
=
휕H
휕HC
×
dHC
dY
+
휕H
휕HB
×
dHB
dY
+
휕H
휕M
×
dM
dY
(8)EH,Y =
(
휕H
휕HC
×
dHC
dY
+
휕H
휕HB
×
dHB
dY
+
휕H
휕M
×
dM
dY
)
×
Y
H
(9)EH,Y =
(
휕H
휕HC
×
dHC
dY
)
×
Y
H
+
(
휕H
휕HB
×
dHB
dY
)
×
Y
H
+
(
휕H
휕M
×
dM
dY
)
×
Y
H
(10)
Y
H
≡
Y
HC
×
HC
H
≡
Y
HB
×
HB
H
≡
Y
M
×
M
H
(11)EH,Y =
휕H
휕HC
HC
H
×
dHC
dY
Y
HC
+
휕H
휕HB
HB
H
×
dHB
dY
Y
HB
+
휕H
휕M
M
H
×
dM
dY
Y
M
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•  the second term is the elasticity of the population’s health status with respect to health-related 
behaviours, habits and living conditions (EH,HB) times the income elasticity of HB (EHB,Y). The prod-
uct of these coefficients (EH,HB × EHB,Y) captures the “behaviour effect” of economic growth on 
people’s health;
•  finally, the third term is the elasticity of the population’s health status with respect to medical 
knowledge (EH,M) times the income elasticity of M (EM,Y). The product of these coefficients 
(EH,M × EM,Y) captures the “knowledge effect” of economic growth on people’s health.
We can therefore rewrite Equation 11 in an insightful way, as follows:
 
where the complex effects of economic growth on health are broken down into their three funda-
mental components: (1) resources; (2) behaviours; and (3) knowledge.
In particular, the magnitude of changes in HC, HB and M due to economic growth is measured by 
an income elasticity coefficient (EHC,Y, EHB,Y and EM,Y, respectively), whereas the magnitude of changes 
in the population’s health status due to changes in HC, HB and M is measured by an output elasticity 
coefficient (EH,HC, EH,HB and EH,M, respectively). The product of each income elasticity times its own 
output elasticity gives the size of the partial effect on people’s health of the corresponding health 
determinant—that is, the separate effect on health of resources, behaviours and knowledge, respec-
tively—and by summing up these three effects, we put back together the income elasticity of the 
population’s health status (i.e. the reactivity of the NCDs’ mortality rate to economic growth).
Finally, a general feature of NCDs is the existence of a delay between the exposure to risk factors, 
the illness’s onset, the health care received and the mortality due to the disease. That is, “today’s 
mortality is affected by yesterday’s exposure, health care, and knowledge, and today’s exposure, 
health care, and knowledge will affect tomorrow’s mortality”, ceteris paribus. In other words, there 
is a temporal lag between H and the independent variables of the health production function (espe-
cially for HB). Consequently, Equation 12 should be read as follows: “during period t, changes in Y 
lead to changes in M, HC, and—for any given cohort of the population under study—HB; in turn, 
changes in M, HB, and HC lead in each cohort to changes in H during period t+n”.
6. Discussion and conclusions
Measuring the stock of medical knowledge, although conceptually plausible, is in fact extremely dif-
ficult. The lack of a reliable quantitative measure of M, however, helps in illustrating an interesting 
feature of this framework. Equation 12 may be reorganized as follows:
 
where the “knowledge effect” is now obtained as a residual after subtracting from the income elas-
ticity of the population’s health status (EH,Y) the effects due to resources and behaviours (EH,HC × EHC,Y 
and EH,HB × EHB,Y), which are both—at least theoretically—observable and measurable.
In Equation 13, we also highlight the fundamental determinants of the resource and behaviour 
effects. On the one hand, the reactivity coefficients of health care and health-related behaviours 
with respect to income (EHC,Y and EHB,Y) are Engel’s elasticities: they tell us how much HC and HB re-
spond to a 1% change in Y. The evolution of these coefficients during economic growth is primarily 
driven by the changing structure of people’s preferences as consumers and citizens.
(12)
EH,Y = EH,HC × EHC,Y
⏟⏞⏞⏞⏞⏟⏞⏞⏞⏞⏟
resources
+ EH,HB × EHB,Y
⏟⏞⏞⏞⏞⏟⏞⏞⏞⏞⏟
behaviours
+ EH,M × EM,Y
⏟⏞⏞⏞⏟⏞⏞⏞⏟
knowledge
(13)EH,M × EM,Y = EH,Y - (
technology
⏞ ⏞
EH,HC × EHC,Y
⏟ ⏟
preferences
+
biology
⏞ ⏞
EH,HB × EHB,Y
⏟ ⏟
preferences
)
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On the other hand, the reactivity coefficients of health status with respect to health care and to 
health-related behaviours (EH,HC and EH,HB) are output elasticities: they tell us how much H responds to 
a 1% change in HC and HB, respectively. These two coefficients form the supply-side channel of the 
model, and their evolution is subject to the technological and biological constraints that character-
ize the health production process.
An elementary numerical example—with hypothetical and simplified data—may help in discuss-
ing the strengths and limitations of Equation 13 as a sort of “pedagogical tool” to decompose the 
impact of economic growth on NCDs’ mortality rate. Let us consider, for instance, the US population, 
in which the age-adjusted mortality rate caused by the main cardiovascular diseases (CVDs) 
declined by about 50% between the early 1980s and the late 2000s (National Center for Health 
Statistics, 2011). During the same period, the US GDP per capita rose by about 60% in constant prices 
(Council of Economic Advisers, 2012). These data imply an income elasticity of health status (EH,Y) of 
around −0.83.
This sharp decline in mortality was accompanied by changes in health care, health-related behav-
iours and medical knowledge. An educated guess for the income and output elasticities of health 
care and health-related behaviours, based upon several economic and epidemiological studies on 
the US economy, might be around + 1.5 and −0.05 for EHC,Y and EH,HC (Miller, Hughes-Cromwick, & 
Roehrig, 2011; Thornton, 2002) and 2.5 and −0.16 for EH,HB and EHB,Y (Ergin, Muntner, Sherwin, & He, 
2004; Ford & Capewell, 2011; Gregg et al., 2005), respectively.
Putting these figures into Equation 13 gives:
 
that is, a “knowledge effect” of around 0.35. In summary, the “behaviour effect” explains approxi-
mately half of the current decline in H. The relatively low elasticity of health-related behaviours to 
income—the reduction in three of the main CVD risk factors (i.e. total cholesterol level, blood pres-
sure and smoking habits)—that occurred during the last few decades (Ford & Capewell, 2011) is 
compensated for by a relatively high elasticity of the health outcome to this reduction in major risk 
factors. On the other hand, despite the high reactivity of health care expenditure to income, the 
inelastic response to H to more resources (i.e. the so-called “flat-of-the-curve medicine” hypothesis) 
generates a resource effect that accounts for less than 10% of the total reduction in the CVDs’ mor-
tality rate. Thus, advances in medical knowledge and changes in health-related behaviours, driven 
by the growth process, are the major forces that influenced the recent evolution of mortality due to 
CVDs in the US population (Ford et al., 2007).
In other words, this sort of “accounting framework” can be utilized either to describe or to meas-
ure how economic growth tends to affect NCDs’ mortality rate, through its influence on the main 
determinants of health. A serious limitation of this latter use is the availability of an appropriate 
information base. To decompose EH,Y into its fundamental components, we need: (1) to collect data 
on many economic and epidemiological variables; (2) to compute a complex index for HB (Ford, Li, 
Zhao, Pearson, & Capewell, 2009; Salvador-Carulla et al., 2013); and (3) to estimate the impact of HC, 
HB and M on NCDs’ mortality rate, holding all other factors constant. As illustrated by ongoing 
research (National Research Council, 2010; Organisation for Economic Co-operation & Development, 
2011), however, measuring the medical and non-medical determinants of people’s health and 
assessing their isolated impact on the health status are difficult tasks to perform.
(14)
EH, M × EM, Y
⏞⏞⏞⏞⏞⏞ ⏞⏞⏞⏞⏞
− 0.35
⏟⏞⏞⏞⏞⏞⏟⏞⏞⏞⏞⏞⏟
knowledge
=
EH, Y
⏞ ⏞
−0.83 − [(
EH, HC
⏞ ⏞
−0.05 ×
EHC, Y
⏞ ⏞
1.5
⏟⏞⏞⏞⏞⏞⏞⏞⏞⏟⏞⏞⏞⏞⏞⏞⏞⏞⏟
resources
−0.075
) + (
EH, HB
⏞ ⏞
2.5 ×
EHB, Y
⏞ ⏞
−0.16
⏟⏞⏞⏞⏞⏞⏞⏞⏞⏟⏞⏞⏞⏞⏞⏞⏞⏞⏟
behaviours
−0.40
)]
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In spite of these empirical weaknesses, this framework is flexible enough to be applied to exam-
ine, at an abstract level, the impact of economic growth on a population’s health in a wide range of 
situations. A closer look at Equations 12 and 13 suggests that this approach is suitable for applica-
tion to other kinds of pathologies, as well as to several different measures of health conditions or 
disease frequencies. For instance, we can measure with H the age-standardized incidence rate of a 
communicable disease in a developing country, and we can use Equations 12 and 13 to investigate 
the channels through which economic growth affects H by way of changes in people’s health-related 
behaviours, in government spending on public health, and in the international transfer of medical 
knowledge.
Finally, a potential insightful use of this framework is the analysis of the impact of the Great 
Recession on the future population health status in developed economies (Grusky, Western, & 
Wimer, 2011). A prolonged and deep recession, accompanied by drastic cuts in public health 
expenditure and by increasing income inequality—as recently experienced by some European coun-
tries—will ultimately affect NCDs’ epidemiology. We are able to investigate the impact of the reces-
sion on the future overall health of populations, especially through the negative effect of a decreasing 
real per capita income on changes in private and public resource allocation to health care and 
health-related behaviours.
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Notes
1. A variety of measures are commonly used to character-
ize the overall health of populations. The dependent 
variable in the health production function can be a 
measure of disease frequencies (such as the incidence 
or prevalence rate), of health outcome (such as the 
mortality or morbidity rate and life expectancy), or even 
of the duration of life combined with some notion of its 
quality (such as the quality-adjusted life years (QALYs) 
or disability-adjusted life years [DALYs]). We focus on 
the mortality rate only to keep the model as simple as 
possible (Breyer, Kifmann, & Zweifel, 2009).
2. In a narrow sense, an Engel’s function shows the 
relationship between the quantity demanded of a single 
good (or the expenditure on a set of goods) and income, 
holding prices constant (Engel, 1895; Lewbel, 2006).
References
Argyrous, G. (2002). Endogenous demand in the theory of 
transformational growth. In M. Setterfield (Ed.), The 
economics of demand-led growth (pp. 237–250). New 
York, NY: Edward Elgar.
Biggs, B., King, L., Basu, S., & Stuckler, D. (2010). Is wealthier 
always healthier? The impact of national income level, 
inequality, and poverty on public health in Latin America. 
Social Science & Medicine, 71, 266–273.
Bishai, D., & O’Neil, J. (2012). Economic growth and better 
health: The UK’s surprising progress. The Lancet, 380, 649. 
http://dx.doi.org/10.1016/S0140-6736(12)61370-1
Bloom, D. E., Cafero, E. T., Jané-Llopis, E., Abrahams-Gessel, S., 
Bloom, L. R., Fathima, S., … Weinstein, C. (2011). The global 
economic burden of non-communicable diseases. Geneva: 
World Economic Forum and Harvard School of Public 
Health.
Bloom, D. E., & Canning, D. (2000). Public Health: The health 
and wealth of nations. Science, 287, 1207–1209. 
http://dx.doi.org/10.1126/science.287.5456.1207
Bonita, R., Beaglehole, R., & Kjellström, T. (2006). Basic 
epidemiology (2nd ed.). Geneva: WHO Press.
Breyer, F., Kifmann, M., & Zweifel, P. (2009). Health economics. 
Heidelberg: Springer.
Canning, D., Bloom, D. E., Jaminson, D. T., & Ruger, P. J. (2012). 
Health and the economy. In M. H. Merson, R. E. Black, &  
A. J. Mills (Eds.), Global health: Diseases, programs, 
systems, and policies (3rd ed., pp. 757–802). Burlington, 
MA: Jones and Bartlett.
Chai, A., & Moneta, A. (2010). Retrospectives: Engel curves. 
Journal of Economic Perspectives, 24, 225–240. 
http://dx.doi.org/10.1257/jep.24.1.225
Chai, A., & Moneta, A. (2013). The evolution of Engel curves 
and its implications for structural change theory. 
Cambridge Journal of Economics, 38, 895–923.
Chan, M. (2014). Message from the Director-General. In World 
Health Organisation (Eds.), Global status report on non-
communicable diseases, 2014 (p. VII). Geneva: WHO Press.
Council of Economic Advisers. (2012). Economic report of the 
President. Washington, DC: United States Government 
Printing Office.
Cutler, D., Deaton, A., & Lleras-Muney, A. (2006). The 
determinants of mortality. Journal of Economic 
Perspectives, 20, 97–120. 
http://dx.doi.org/10.1257/jep.20.3.97
Deaton, A. (2008). Income, health, and well-being around the 
World: Evidence from the Gallup World Poll. Journal of 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 B
rad
fo
rd
] a
t 0
8:1
9 1
3 M
ay
 20
15
 
Page 9 of 10
Cohen et al., Cogent Economics & Finance (2015), 3: 1045215
http://dx.doi.org/10.1080/23322039.2015.1045215
Economic Perspectives, 22, 53–72. 
http://dx.doi.org/10.1257/jep.22.2.53
Ecob, R., & Smith, G. D. (1999). Income and health: What is 
the nature of the relationship? Social Science & Medicine, 
48, 693–705.
Engel, E. (1895). Die Lebenskosten Belgischer Arbeiter-
Familien Fruher and jetzt. International Statistical 
Institute Bulletin, 9, 1–74.
Engelgau, M., Rosenhouse, S., El-Saharty, S., & Mahal, A. (2011). 
The economic effect of noncommunicable diseases on 
households and nations: A review of existing evidence. 
Journal of Health Communication, 16, 75–81. 
http://dx.doi.org/10.1080/10810730.2011.601394
Ergin, A., Muntner, P., Sherwin, R., & He, J. (2004). Secular 
trends in cardiovascular disease mortality, incidence, 
and case fatality rates in adults in the United States. The 
American Journal of Medicine, 117, 219–227. 
http://dx.doi.org/10.1016/j.amjmed.2004.03.017
Folland, S., Goodman, A. C., & Stano, M. (2013). Economics of 
health and health care (7th ed.). Upper Saddle River, NJ: 
Prentice Hall.
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., 
Kottke, T. E., … Capewell, S. (2007). Explaining the decrease 
in US deaths from coronary disease, 1980–2000. New 
England Journal of Medicine, 356, 2388–2398. 
http://dx.doi.org/10.1056/NEJMsa053935
Ford, E. S., & Capewell, S. (2011). Proportion of the decline 
in cardiovascular mortality disease due to prevention 
versus treatment: Public health versus clinical care. 
Annual Review of Public Health, 32, 5–22. http://dx.doi.
org/10.1146annurev-publhealth-031210-101211
Ford, E. S., Li, C., Zhao, G., Pearson, W. S., & Capewell, S. (2009). 
Trends in the prevalence of low risk factor burden for 
cardiovascular disease among united states adults. 
Circulation, 120, 1181–1188. 
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.835728
Gregg, E. W., Cheng, Y. J., Cadwell, B. L., Imperatore, G., 
Williams, D. E., Flegal, K. M., … Williamson, D. F. (2005). 
Secular trends in cardiovascular disease risk factors 
according to body mass index in US adults. JAMA, 293, 
1868–1874. 
http://dx.doi.org/10.1001/jama.293.15.1868
Grossman, M. (1972). On the concept of health capital and 
the demand for health. Journal of Political Economy, 80, 
223–255. 
http://dx.doi.org/10.1086/jpe.1972.80.issue-2
Grusky, D. B., Western, B., & Wimer, C. (2011). The great 
recession. New York, NY: Russel Sage Foundation.
Jemal, A., Center, M. M., De Santis, C., & Ward, E. M. (2010). 
Global patterns of cancer incidence and mortality rates 
and trends. Cancer Epidemiology, Biomarkers & Prevention, 
19, 1893–1907.
Lewbel, A. (2006). Engel curves. The new Palgrave dictionary of 
economics. London: Palgrave.
López-Casasnovas, G., Rivera, B., & Currais, L. (Eds.). (2005). 
Health and economic growth. Findings and policy 
implications. Cambridge, MA: MIT Press.
McQueen, D. (Ed.). (2013). Global handbook on non-
communicable diseases and health promotion. Heidelberg: 
Springer.
Miller, G., Hughes-Cromwick, P., & Roehrig, C. (2011). National 
spending on cardiovascular disease, 1996–2008. Journal 
of the American College of Cardiology, 58, 2017–2019. 
http://dx.doi.org/10.1016/j.jacc.2011.08.018
National Center for Health Statistics. (2011). Health, United 
States, 2010: With special feature on death and dying. 
Hyattsville, MD: US Government Printing Office.
National Research Council. (2010). Accounting for health and 
health care: Approaches to measuring the sources and 
costs of their improvement (Panel to Advance a Research 
Program on the Design of National Health Accounts). 
Washington, DC: NCR – The National Academies Press.
Organisation for Economic Co-operation and Development. 
(2011). A system of health accounts. Paris: OECD 
Publishing.
Pasinetti, L. L. (1981). Structural change and economic growth. 
Cambridge: Cambridge University Press.
Popkin, B. M. (2006). Global nutrition dynamics: The world is 
shifting rapidly toward a diet linked with NCDs. American 
Journal of Clinical Nutrition, 84, 289–298.
Pritchett, L., & Summers, L. H. (1996). Wealthier is healthier. 
The Journal of Human Resources, 31, 841–868. 
http://dx.doi.org/10.2307/146149
Sachs, J. D. (2001). Macroeconomics and health: Investing 
in health for economic development (Report of the 
Commission on Macroeconomics and Health). Geneva: 
WHO Press.
Salvador-Carulla, L., Alonso, F., Gomez, R., Walsh, C. O., 
Almenara, J., Ruiz, M., … eVITAL Group. (2013). Basic 
concepts in the taxonomy of health-related behaviors, 
habits and lifestyle. International Journal of Environmental 
Research and Public Health, 10, 1963–1976. 
http://dx.doi.org/10.3390/ijerph10051963
Setterfield, M. (Ed.). (2002). The economics of demand-led 
growth: Challenging the supply-side vision of the long run. 
Cheltenham, UK: Edward Elgar.
Sloan, F. A., & Hsieh, C. R. (2012). Health economics. Cambridge, 
MA: MIT Press.
Suhrcke, M., Nugent, R. A., Stuckler, D., & Rocco, L. (2006). 
Chronic disease: An economic perspective. London: Oxford 
Health Alliance.
Thornton, J. A. (2002). Estimating a health production function 
for the US: Some new evidence. Applied Economics, 34, 
59–62. http://dx.doi.org/10.1080/00036840010025650
Weil, D. N. (2012). Economic growth (3rd ed.). New York, NY: 
Pearson.
World Health Organisation. (2014). Global status report on non-
communicable diseases, 2014. Geneva: WHO Press.
Yach, D., Mensah, G. A., Hawkes, C., Epping-Jordan, J. E., & 
Steyn, K. (2012). Chronic diseases and risk. In M. Merson, 
R. E. Black, & A. J. Mills (Eds.), Global health: Diseases, 
programs, systems and policies (3rd ed.). (pp. 345–396). 
Burlington, MA: Jones & Bartlett.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 B
rad
fo
rd
] a
t 0
8:1
9 1
3 M
ay
 20
15
 
Page 10 of 10
Cohen et al., Cogent Economics & Finance (2015), 3: 1045215
http://dx.doi.org/10.1080/23322039.2015.1045215
© 2015 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license.
You are free to: 
Share — copy and redistribute the material in any medium or format  
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made.  
You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.  
No additional restrictions  
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Cogent Economics & Finance (ISSN: 2332-2039) is published by Cogent OA, part of Taylor & Francis Group. 
Publishing with Cogent OA ensures:
• Immediate, universal access to your article on publication
• High visibility and discoverability via the Cogent OA website as well as Taylor & Francis Online
• Download and citation statistics for your article
• Rapid online publication
• Input from, and dialog with, expert editors and editorial boards
• Retention of full copyright of your article
• Guaranteed legacy preservation of your article
• Discounts and waivers for authors in developing regions
Submit your manuscript to a Cogent OA journal at www.CogentOA.com
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 B
rad
fo
rd
] a
t 0
8:1
9 1
3 M
ay
 20
15
 
